Articles published in Pharmaceutical Regulatory Affairs: Open Access have been cited by esteemed scholars and scientists all around the world.
Pharmaceutical Regulatory Affairs: Open Access has got h-index 12, which means every article in Pharmaceutical Regulatory Affairs: Open Access has got 12 average citations.
Following are the list of articles that have cited the articles published in Pharmaceutical Regulatory Affairs: Open Access.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
Total published articles |
60 | 61 | 60 | 60 | 8 | 15 | 18 |
Research, Review articles and Editorials |
2 | 2 | 4 | 9 | 4 | 7 | 12 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
48 | 48 | 56 | 51 | 4 | 8 | 6 |
Conference proceedings |
0 | 0 | 10 | 10 | 0 | 41 | 48 |
Citations received as per Google Scholar, other indexing platforms and portals |
597 | 400 | 49 | 62 | 76 | 75 | 53 |
| Journal total citations count | 533 |
| Journal impact factor | 2.15 |
| Journal 5 years impact factor | 2.86 |
| Journal cite score | 2.85 |
| Journal h-index | 12 |
| Journal h-index since 2019 | 9 |
Jabeen K, Shakoor S, Hasan R (2015) Fluoroquinolone-resistant tuberculosis: implications in settings with weak healthcare systems. Int J Infectious Diseases 32: 118-123. |
|
Bbosa GS, Mwebaza N, Odda J, Kyegombe DB, Ntale M (2014) Antibiotics/antibacterial drug use, their marketing and promotion during the post-antibiotic golden age and their role in emergence of bacterial resistance. Health 6: 410. |
|
Zaura E, Brandt BW, de Mattos MJ, Buijs MJ, Caspers MP, et al. (2015) Same exposure but two radically different responses to antibiotics: resilience of the salivary microbiome versus long-term microbial shifts in feces. MBio 6:e01693-15. |
|
Ziegler A, König IR (2014) Correspondence (reply): In Reply. Deutsches Ärzteblatt International 111: 68. |
|
Niederhofer H (2014) Correspondence (letter to the editor): Difficult to Reconcile. Deutsches Ärzteblatt International 111: 67. |
|
Harris K, Dickinson R, Raynor DK, MacDonald J, Knapp P (2015) Changes in side effect risk communication in patient information leaflets over the past decade: results of a survey. Drug safety 38: 721-727. |
|
Borup R, Kaae S, Minssen T, Traulsen J (2016) Fighting falsified medicines with paperwork–a historic review of Danish legislation governing distribution of medicines. J Pharmaceut Policy Practice 9: 30. |
|
Sud S, Sud Khyati S (2016) AN OVERVIEW OF LAWS GOVERNING PHARMACY IN INDIA. WORLD J PHARMACEUT RES 9: 480-494. |
|
Fleming GA (2015) Regulatory Considerations for Early Clinical Development of Drugs for Diabetes, Obesity, and Cardiometabolic Disorders. InTranslational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development: 283-304. |
|
Fleming GA (2014) 12 Regulatory Considerations for Early Clinical Development. Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development: A Focus on Early Phase Clinical Studies 29: 283. |
|
Archives T, Latham J. icon Disiciencia. |
|
DELLA SOMMINISTRAZIONE DV. APPELLO PER UNA MORATORIA DELLA SOMMINISTRAZIONE DEL VACCINO CONTRO IL PAPILLOMAVIRUS. |
|
LAS VACUNAS AJ. PEDIATRIA 3000. |
|
Matsudaira T, Takahashi Y, Matsuda K, Ikeda H, Usui K, et al. (2016) Cognitive dysfunction and regional cerebral blood flow changes in Japanese females after human papillomavirus vaccination. Neurology Clinical Neuroscience 4: 220-227. |
|
Perenich T (2014) Vaccines and Chiropractic: Evidence-Based Medicine or Medical Dogma?. Dynamic Chiropractic 32. |
|
Kanduc D, Shoenfeld Y (2016) From HBV to HPV: Designing vaccines for extensive and intensive vaccination campaigns worldwide. Autoimmunity Reviews 15: 1054-1061. |
|
Danelon M (2015) Ignorance Production and Corporate Science. |
|
Perenich T. Vaccines and Chiropractic: Evidence-Based Medicine or Medical Dogma?. |
|
NULL G, GALE R (2012) The War Against Chuck Hagel. Aletho News. |
|
Melancon SI (2014) One Less Risk, Or One Less Girl? Situating Gardasil and Cervical Cancer Risk in the Context of Risk-Reduction Medicine. |
|
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 